BioFire® Joint Infection Panel
1 Test. 39 Targets. ~1 Hour.
Newly cleared under an FDA De Novo authorization, the BioFire JI Panel offers an improved diagnostic approach to joint infections. Instead of lengthy and laborious—and often inconclusive—send-out serial testing, the BioFire JI Panel provides fast, accurate, and comprehensive answers on 39 clinically relevant targets, including 31 causative pathogens and 8 antimicrobial resistance markers.
Benefits of the BioFire JI Panel
Fast, accurate, and comprehensive testing with the BioFire JI Panel may offer several benefits. For example, CLIA-moderate complexity supports testing directly onsite. The test requires only a minimal sample to test for a broad menu of possible pathogens and antimicrobial resistance genes, providing results in about an hour.
Explore More about the BioFire JI Panel
The Technology Behind our System
Multiplex PCR is the backbone of our syndromic approach to infection disease diagnostics.
The Syndromic Approach
Syndromic testing is a symptom-driven approach that targets multiple pathogens in one, rapid test.
Benefits of POC Testing
Patients have come to expect fast and convenient testing. But POC testing offers benefits to patients and clinics alike.